The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea: Mild OSA and cytokines
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
It is widely accepted that obstructive sleep apnoea (OSA) is linked with cardiovascular diseases. The relationship is complex and remains still poorly understood. The presence of chronic systemic inflammation has been connected with pathogenesis of both OSA and cardiovascular diseases. While atherogenesis is believed to be a process of many years, little is known about the potential impact of the largest OSA subgroup, mild OSA, on the development of cardiovascular diseases. The aim of the present study was to assess whether untreated mild OSA is associated with an activation of inflammatory cytokine system. The adult study population consisted of two groups: 84 patients with mild OSA [apnoea-hypopnoea index (AHI) 5-15 h(-1)] and 40 controls (AHI <5 h(-1)). Serum concentrations of pro- and anti-inflammatory cytokines were measured before any interventions. After adjustments for age, sex, body mass index, fat percentage, most important cardiometabolic and inflammatory diseases, and non-steroidal anti-inflammatory medication, the mean level of tumour necrosis factor-alpha was significantly elevated (1.54 versus 1.17 pg mL(-1), P = 0.004), whereas the level of interleukin-1 beta (IL-1 beta) was reduced (0.19 versus 0.23 pg mL(-1), P = 0.004) in patients with mild OSA compared with controls. The concentrations of the protective anti-inflammatory cytokines, interleukin-10 (1.28 versus 0.70 pg mL(-1), P < 0.001) and interleukin-1 receptor antagonist (478 versus 330 pg mL(-1), P = 0.003) were elevated in the OSA group. The concentrations of C-reactive protein increased, but IL-1 beta decreased along with the increase of AHI. Mild OSA was found to be associated not only with the activation of the pro-inflammatory, but also with the anti-inflammatory systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973 · cited 1×
“OSA affects mainly the working-age population, and has been found to be independently associated with cardiovascular diseases and type 2 diabetes (Peppard et al., 2000; Shahar et al., 2001; Shamsuzzaman et al., 2003; Tuomilehto et al., 2008; Young et al., 2002).”
BackgroundEpidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244 · cited 2×
“It has been estimated that one out of every five adults suffers from at least a mild degree of OSA (Young et al., 2002).”
BackgroundNieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369 · cited 1×
“In addition to hypertension, coronary artery disease, cerebrovascular disease and heart failure are associated with moderate to severe OSA (Nieto et al., 2000; Shamsuzzaman et al., 2003).”
BackgroundSleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901 · cited 1×
“OSA affects mainly the working-age population, and has been found to be independently associated with cardiovascular diseases and type 2 diabetes (Peppard et al., 2000; Shahar et al., 2001; Shamsuzzaman et al., 2003; Tuomilehto et al., 2008; Young et al., 2002).”
BackgroundRidker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429 · cited 1×
“Interestingly, both TNF-a and IL-6 have also been associated with a poor outcome in acute coronary events (Ridker et al., 2000a,b).”
BackgroundAdipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Collop, N. A., Anderson, W. M., Boehlecke, B., Claman, D., Goldberg, R., Gottlieb, D. J., Hudgel, D., Sateia, M., Schwab, R., & Portable Monitoring Task Force of the American Academy of Sleep Medicine (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27032 · Cited by 1,550
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Obstructive sleep apnoea syndrome – an oxidative stress disorder
Lavie, L. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0261 · Cited by 993 · cited 2×
“In the pathogenesis of cardiovascular diseases in patients with OSA, inflammation is one potential mechanism along with increased sympathetic activity, decreased baroreflex sensitivity, endothelial dysfunction, oxidative stress, and leucocyte adhesion and accumulation on endothelial cells (Carlson et al., 1996; Hedner…”
Background
Cited by
Serum Inflammatory Markers in Obstructive Sleep Apnea: A Meta-Analysis
Nadeem, R., Molnar, J., Madbouly, E. M., Nida, M., Aggarwal, S., Sajid, H., Naseem, J., & Loomba, R. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3070 · Cited by 481
Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines
Kheirandish-Gozal, L., & Gozal, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030459 · Cited by 340
Obesity and obstructive sleep apnea – Clinical significance of weight loss
Tuomilehto, H., Seppä, J., & Uusitupa, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.08.002 · Cited by 215
Self-citationThe Link Between Obstructive Sleep Apnea and Cardiovascular Disease
Bauters, F., Rietzschel, E. R., Hertegonne, K. B. C., & Chirinos, J. A. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0556-z · Cited by 153
Smagula, S. F., Stone, K. L., Redline, S., Ancoli-Israel, S., Barrett-Connor, E., Lane, N. E., Orwoll, E. S., & Cauley, J. A. (2016) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000312 · Cited by 116
Metadata
- Authors
- SAHLMAN, J., MIETTINEN, K., PEUHKURINEN, K., SEPPÄ, J., PELTONEN, M., HERDER, C., PUNNONEN, K., VANNINEN, E., GYLLING, H., PARTINEN, M., UUSITUPA, M., TUOMILEHTO, H., & ON BEHALF OF THE KUOPIO SLEEP APNOEA GROUP
- Venue
- Journal of Sleep Research
- Publisher
- Wiley
- Published
- 2009-12-16
- Volume
- 19
- Issue
- 2
- Pages
- 341-348
- ISSN
- 0962-1105 (ISSN-L)
- 1365-2869
- OpenAlex
- W1164096230
- Cited by
- 76
- References
- 16
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea: Mild OSA and cytokines. https://app.cochat.ai/papers/10.1111/j.1365-2869.2009.00787.x
- The paper
- SAHLMAN, J., MIETTINEN, K., PEUHKURINEN, K., SEPPÄ, J., PELTONEN, M., HERDER, C., PUNNONEN, K., VANNINEN, E., GYLLING, H., PARTINEN, M., UUSITUPA, M., TUOMILEHTO, H., & ON BEHALF OF THE KUOPIO SLEEP APNOEA GROUP. (2009). The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea: Mild OSA and cytokines. Journal of Sleep Research. https://doi.org/10.1111/j.1365-2869.2009.00787.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.